BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lata J, Jurankova J, Kopacova M, Vitek P. Probiotics in hepatology. World J Gastroenterol 2011; 17(24): 2890-2896 [PMID: 21734800 DOI: 10.3748/wjg.v17.i24.2890]
URL: https://www.wjgnet.com/1007-9327/full/v17/i24/2890.htm
Number Citing Articles
1
Eamonn M.M. Quigley, Catherine Stanton, Eileen F. Murphy. The gut microbiota and the liver. Pathophysiological and clinical implicationsJournal of Hepatology 2013; 58(5): 1020 doi: 10.1016/j.jhep.2012.11.023
2
Safoora Nabavi, Maryam Rafraf, Mohammad-hossein Somi, Aziz Homayouni-Rad, Mohammad Asghari-Jafarabadi. Probiotic yogurt improves body mass index and fasting insulin levels without affecting serum leptin and adiponectin levels in non-alcoholic fatty liver disease (NAFLD)Journal of Functional Foods 2015; 18: 684 doi: 10.1016/j.jff.2015.08.031
3
Wei-Wei Wang, Yu Zhang, Xiao-Bing Huang, Nan You, Lu Zheng, Jing Li. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunctionWorld Journal of Gastroenterology 2017; 23(38): 6983-6994 doi: 10.3748/wjg.v23.i38.6983
4
Zelin Gu, Yanfeng Wu, Yu Wang, Haiyue Sun, Ying You, Chunhong Piao, Junmei Liu, Yuhua Wang. Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver InjuryJournal of Medicinal Food 2020; 23(2): 114 doi: 10.1089/jmf.2018.4357
5
Thierry Thevenot, Gilles Blasco, Natacha Grelat, Sébastien Pili-Floury. L’antibioprophylaxie primaire de l’infection spontanée d’ascite du patient cirrhotique est une affaire de cible !La Presse Médicale 2012; 41(12): 1168 doi: 10.1016/j.lpm.2012.07.021
6
Hisashi Hidaka, Satoshi Tanabe, Haruki Uojima, Xue Shao, Shuichiro Iwasaki, Naohisa Wada, Kousuke Kubota, Yoshiaki Tanaka, Takahide Nakazawa, Akitaka Shibuya, Shigehiro Kokubu, Wasaburo Koizumi. Long‐term observation in patients with esophageal varices after endoscopic variceal ligation accompanied with 24‐hour pH monitoringHepatology Research 2020; 50(11): 1255 doi: 10.1111/hepr.13562
7
German Soriano, Carlos Guarner. Probiotics in cirrhosis: do we expect too much?Liver International 2013; 33(10): 1451 doi: 10.1111/liv.12288
8
Jun Xu, Rui Ma, Li-Feng Chen, Li-Jun Zhao, Kan Chen, Ren-Bing Zhang. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trialsHepatobiliary & Pancreatic Diseases International 2014; 13(4): 354 doi: 10.1016/S1499-3872(14)60280-0
9
Manish Kumar Lunia, Barjesh Chander Sharma, Praveen Sharma, Sanjeev Sachdeva, Siddharth Srivastava. Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled TrialClinical Gastroenterology and Hepatology 2014; 12(6): 1003 doi: 10.1016/j.cgh.2013.11.006
10
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology2017; : 743 doi: 10.1016/B978-0-12-804274-8.00053-9
11
Azumi Ishizaki, Xiuqiong Bi, Lam Nguyen, Kazunori Matsuda, Hung Pham, Chung Phan, Dung Khu, Hiroshi Ichimura. Effects of Short-Term Probiotic Ingestion on Immune Profiles and Microbial Translocation among HIV-1-Infected Vietnamese ChildrenInternational Journal of Molecular Sciences 2017; 18(10): 2185 doi: 10.3390/ijms18102185
12
Garmen A. Woo, Christopher O'Brien. Long-term Management of Alcoholic Liver DiseaseClinics in Liver Disease 2012; 16(4): 763 doi: 10.1016/j.cld.2012.08.007
13
Eamonn M Quigley, Howard P Monsour. The gut microbiota and the liver: implications for clinical practiceExpert Review of Gastroenterology & Hepatology 2013; 7(8): 723 doi: 10.1586/17474124.2013.848167
14
Mehmet Öztürk, Merve Meterelliyöz. Practical identification of human originated Lactobacillus species by amplified ribosomal DNA restriction analysis (ARDRA) for probiotic useMolecular Biology Reports 2015; 42(8): 1323 doi: 10.1007/s11033-015-3877-7
15
Thierry Thevenot, Thibault Degand, Natacha Grelat, Laure Elkrief, Camille Christol, Richard Moreau, Jean Henrion, Jean-François Cadranel, Frances Sheppard, Christophe Bureau, Vincent di Martino, Arnaud Pauwels. A French national survey on the use of antibiotic prophylaxis in cirrhotic patientsLiver International 2013; 33(3): 389 doi: 10.1111/liv.12093
16
Hiroshi Fukui. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemiaWorld Journal of Hepatology 2015; 7(3): 425-442 doi: 10.4254/wjh.v7.i3.425
17
David W. Victor, Eamonn M.M. Quigley. Hepatic Encephalopathy Involves Interactions Among the Microbiota, Gut, BrainClinical Gastroenterology and Hepatology 2014; 12(6): 1009 doi: 10.1016/j.cgh.2014.01.022
18
Rebecca D. Norton, Catherine E. Lenox, Paul Manino, James C. Vulgamott. Nutritional Considerations for Dogs and Cats with Liver DiseaseJournal of the American Animal Hospital Association 2016; 52(1): 1 doi: 10.5326/JAAHA-MS-6292R2
19
Eva Román, Juan Camilo Nieto, Cristina Gely, Sílvia Vidal, Marta Pozuelo, Maria Poca, Cándido Juárez, Carlos Guarner, Chaysavanh Manichanh, Germán Soriano. Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized TrialHepatology Communications 2019; 3(5): 632 doi: 10.1002/hep4.1325
20
Norberto C. Chávez-Tapia, Leticia González-Rodríguez, MinSeung Jeong, Yanine López-Ramírez, Varenka Barbero-Becerra, Eva Juárez-Hernández, Juan L. Romero-Flores, Marco Arrese, Nahúm Méndez-Sánchez, Misael Uribe. Current evidence on the use of probiotics in liver diseasesJournal of Functional Foods 2015; 17: 137 doi: 10.1016/j.jff.2015.05.009
21
Matthew A. Ciorba. A Gastroenterologist's Guide to ProbioticsClinical Gastroenterology and Hepatology 2012; 10(9): 960 doi: 10.1016/j.cgh.2012.03.024
22
Xiao-Meng WANG, Xiao-Bo LI, Ying PENG. Impact of Qi -invigorating traditional Chinese medicines on intestinal flora: A basis for rational choice of prebioticsChinese Journal of Natural Medicines 2017; 15(4): 241 doi: 10.1016/S1875-5364(17)30041-9
23
Zelin Gu, Yanlong Liu, Shumeng Hu, Ying You, Wancong Li, Yuhua Wang. Probiotics for Alleviating Alcoholic Liver InjuryGastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/9097276
24
Elisabet Sánchez, Juan C. Nieto, Ana Boullosa, Silvia Vidal, Francesc J. Sancho, Giacomo Rossi, Pau Sancho-Bru, Rosa Oms, Beatriz Mirelis, Cándido Juárez, Carlos Guarner, Germán Soriano. VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosisLiver International 2015; 35(3): 735 doi: 10.1111/liv.12566
25
Robert S. Lo, Andrew S. Austin, Jan G. Freeman. Association of Mannose-Binding Lectin Gene Polymorphisms with Liver Diseases: A ReviewOpen Medicine Journal 2018; 5(1): 39 doi: 10.2174/1874220301805010039
26
Mayank Sharma, Sanjay Bhat, Kalyan Dutt, Pulkit Sharma, Jasra Ali Bhat. RANDOMIZED CONTROLLED TRIAL OF LACTULOSE AND LACTULOSE PLUS PROBIOTICS IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHYJournal of Evidence Based Medicine and Healthcare 2014; 1(9): 1125 doi: 10.18410/jebmh/2014/166
27
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathyCochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
28
Ding Shi, Longxian Lv, Daiqiong Fang, Wenrui Wu, Chenxia Hu, Lichen Xu, Yanfei Chen, Jing Guo, Xinjun Hu, Ang Li, Feifei Guo, Jianzhong Ye, Yating Li, Dewi Andayani, Lanjuan Li. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in ratsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07091-1
29
Julian R Marchesi, David H Adams, Francesca Fava, Gerben D A Hermes, Gideon M Hirschfield, Georgina Hold, Mohammed Nabil Quraishi, James Kinross, Hauke Smidt, Kieran M Tuohy, Linda V Thomas, Erwin G Zoetendal, Ailsa Hart. The gut microbiota and host health: a new clinical frontierGut 2016; 65(2): 330 doi: 10.1136/gutjnl-2015-309990
30
Chandana Pande, Ashish Kumar, Shiv Kumar Sarin. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitisEuropean Journal of Gastroenterology & Hepatology 2012; 24(7): 831 doi: 10.1097/MEG.0b013e3283537d61
31
Sudhir Maharshi, Barjesh Chander Sharma. Diagnosis and Management of Hepatic Encephalopathy2018; : 99 doi: 10.1007/978-3-319-76798-7_7
32
S. Nabavi, M. Rafraf, M.H. Somi, A. Homayouni-Rad, M. Asghari-Jafarabadi. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver diseaseJournal of Dairy Science 2014; 97(12): 7386 doi: 10.3168/jds.2014-8500
33
Antonella Borrelli, Patrizia Bonelli, Franca Maria Tuccillo, Ira D. Goldfine, Joseph L. Evans, Franco Maria Buonaguro, Aldo Mancini. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approachesRedox Biology 2018; 15: 467 doi: 10.1016/j.redox.2018.01.009
34
Sneha P. Bhatia. Advances in Food Science and Nutrition2013; : 257 doi: 10.1002/9781118865606.ch8
35
Edna Strauss. The impact of bacterial infections on survival of patients with decompensated cirrhosisAnnals of Hepatology 2014; 13(1): 7 doi: 10.1016/S1665-2681(19)30899-3
36
Jianwen Jiang, Zhigang Ren, Shusen Zheng. Infectious MicroecologyAdvanced Topics in Science and Technology in China 2014; : 333 doi: 10.1007/978-3-662-43883-1_13
37
Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, Guglielmo M Trovato. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemicsEPMA Journal 2014; 5(1) doi: 10.1186/1878-5085-5-21
38
Yasushi Okura, Tadashi Namisaki, Shinya Sato, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Kenichiro Seki, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Yukihisa Fujinaga, Takuya Kubo, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Koh Kitagawa, Tsuyoshi Mashitani, Hiroyuki Ogawa, Koji Ishida, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosisHepatology Research 2019; 49(2): 232 doi: 10.1111/hepr.13249